By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences is laying off 130 employees, or 28 percent of its total workforce,it announced after the close of the market on Tuesday.

The layoffs are occurring companywide, but its R&D operations are most affected by the cuts, the Palo Alto, Calif.-based sequencing technology firm said in a document filed with the US Securities and Exchange Commission.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.